Skip to main content
Top
Published in: Virchows Archiv 5/2009

01-05-2009 | Original Article

Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density

Authors: Valeria Barresi, Enrica Vitarelli, Serenella Cerasoli

Published in: Virchows Archiv | Issue 5/2009

Login to get access

Abstract

The immunoexpression of the antiangiogenic factor semaphorin3A (SEMA3A) was evaluated in a series of meningiomas. Then, its correlations with the microvessel density (MVD) of the tumors and with the clinicopathological parameters as well with the survival time or recurrence-free interval were investigated. A positive SEMA3A immunostaining was found in most of meningiomas and a significant association was found between a high expression of this protein and a low MVD of the tumors. Moreover, a low SEMA3A immunoexpression was significantly correlated with a higher recurrence rate of meningiomas. In conclusion, our findings suggest a role for SEMA3A as an antiangiogenic factor in meningiomas with its decrease being associated with the development of recurrences. The supplementation of SEMA3A might be used in novel therapeutic antiangiogenic strategies to prevent the recurrence of highly vascularized meningiomas.
Literature
1.
go back to reference Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon, pp 164–172 Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon, pp 164–172
2.
go back to reference Perry A, Stafford SL, Scheithauer BW et al (1999) “Malignancy” in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046–2056PubMed Perry A, Stafford SL, Scheithauer BW et al (1999) “Malignancy” in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046–2056PubMed
3.
go back to reference Barresi V, Cerasoli S, Vitarelli E et al (2007) Density of microvessel positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156PubMedCrossRef Barresi V, Cerasoli S, Vitarelli E et al (2007) Density of microvessel positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156PubMedCrossRef
4.
go back to reference Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934PubMed Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934PubMed
5.
go back to reference Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217–227PubMedCrossRef Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217–227PubMedCrossRef
6.
go back to reference Guttmann-Raviv N, Shraga-Heled N, Varshavsky A et al (2007) Semaphorin-3A and semaphoring-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 282:26294–26305PubMedCrossRef Guttmann-Raviv N, Shraga-Heled N, Varshavsky A et al (2007) Semaphorin-3A and semaphoring-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 282:26294–26305PubMedCrossRef
7.
go back to reference Soker S, Takashima S, Miao HQ et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92:735–745PubMedCrossRef Soker S, Takashima S, Miao HQ et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92:735–745PubMedCrossRef
8.
go back to reference Soker S, Maio HQ, Nomi M et al (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165 receptor binding. J Biol Chem 85:357–368 Soker S, Maio HQ, Nomi M et al (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165 receptor binding. J Biol Chem 85:357–368
9.
go back to reference Miao HQ, Soker S, Feiner L et al (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 12:233–242 Miao HQ, Soker S, Feiner L et al (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 12:233–242
10.
go back to reference Narazaki M, Tosato G (2006) Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107:3892–3901PubMedCrossRef Narazaki M, Tosato G (2006) Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107:3892–3901PubMedCrossRef
11.
go back to reference Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39PubMedCrossRef Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39PubMedCrossRef
12.
go back to reference Barresi V, Grosso M, Vitarelli E et al (2008) Endoglin (CD105) immuno-expression in human foetal and neonatal lungs. Histol Histopathol 23:701–708PubMed Barresi V, Grosso M, Vitarelli E et al (2008) Endoglin (CD105) immuno-expression in human foetal and neonatal lungs. Histol Histopathol 23:701–708PubMed
13.
go back to reference Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478PubMedCrossRef Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478PubMedCrossRef
14.
go back to reference Barresi V, Vitarelli E, Tuccari G et al (2008) Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med 132:1807–1812PubMed Barresi V, Vitarelli E, Tuccari G et al (2008) Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med 132:1807–1812PubMed
15.
go back to reference Villegas G, Tufro A (2002) Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Gene Expr Patterns 2:151–155PubMedCrossRef Villegas G, Tufro A (2002) Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Gene Expr Patterns 2:151–155PubMedCrossRef
16.
go back to reference Gougos A, St Jacques S, Greaves A et al (1992) Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83–92PubMedCrossRef Gougos A, St Jacques S, Greaves A et al (1992) Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83–92PubMedCrossRef
17.
go back to reference Perry A, Stafford SL, Scheithauer BW et al (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef Perry A, Stafford SL, Scheithauer BW et al (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef
18.
go back to reference Ding S, Li C, Lin S et al (2006) Comparative evaluation of micorvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861–866PubMedCrossRef Ding S, Li C, Lin S et al (2006) Comparative evaluation of micorvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861–866PubMedCrossRef
19.
go back to reference Saad RS, El-Gohary Y, Memari E et al (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955–961PubMedCrossRef Saad RS, El-Gohary Y, Memari E et al (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955–961PubMedCrossRef
20.
go back to reference Folkman J (1995) Clinical applications of angiogenic research. N Eng J Med 333:1757–1763CrossRef Folkman J (1995) Clinical applications of angiogenic research. N Eng J Med 333:1757–1763CrossRef
21.
go back to reference Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364PubMedCrossRef Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364PubMedCrossRef
22.
go back to reference Pistolesi S, Boldrini L, Gisfredi S et al (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118–25PubMedCrossRef Pistolesi S, Boldrini L, Gisfredi S et al (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118–25PubMedCrossRef
23.
go back to reference Provias J, Claffey K, delAguila L et al (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026PubMedCrossRef Provias J, Claffey K, delAguila L et al (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026PubMedCrossRef
24.
go back to reference Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379–389PubMedCrossRef Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379–389PubMedCrossRef
25.
go back to reference Catalano A, Caprari P, Rodilossi S et al (2004) Crosstalk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 18:358–360PubMed Catalano A, Caprari P, Rodilossi S et al (2004) Crosstalk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 18:358–360PubMed
26.
go back to reference Catalano A, Caprari P, Moretti S et al (2006) Semaphorin-3A is expressed by tumour cells and alters T-cell signal transduction and function. Blood 107:3321–3329PubMedCrossRef Catalano A, Caprari P, Moretti S et al (2006) Semaphorin-3A is expressed by tumour cells and alters T-cell signal transduction and function. Blood 107:3321–3329PubMedCrossRef
27.
go back to reference Müller MW, Giese NA, Swiercz JM et al (2007) Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121:2421–2433PubMedCrossRef Müller MW, Giese NA, Swiercz JM et al (2007) Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121:2421–2433PubMedCrossRef
28.
go back to reference Osada R, Horiuchi A, Kikuchi N et al (2006) Expression of semaphorins, vascular endothelial growth factor and their common receptor neuropilins and allelic loss of semaphorin locus in epithaelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphoring is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37:1414–1425PubMedCrossRef Osada R, Horiuchi A, Kikuchi N et al (2006) Expression of semaphorins, vascular endothelial growth factor and their common receptor neuropilins and allelic loss of semaphorin locus in epithaelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphoring is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37:1414–1425PubMedCrossRef
29.
go back to reference Miller DW, Graulich W, Karges B et al (1999) Elevated expression of endoglin, a component of the TGF-ß receptor complex, correlates with proliferation of tumour endothelial cells. Int J Cancer 81:568–572PubMedCrossRef Miller DW, Graulich W, Karges B et al (1999) Elevated expression of endoglin, a component of the TGF-ß receptor complex, correlates with proliferation of tumour endothelial cells. Int J Cancer 81:568–572PubMedCrossRef
30.
go back to reference Christov C, Lechapt-Zalcman E, Adle-Biassette H et al (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420PubMedCrossRef Christov C, Lechapt-Zalcman E, Adle-Biassette H et al (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420PubMedCrossRef
31.
go back to reference Kamitani H, Masuzawa H, Kanazawa I et al (2001) Recurrence of convexity meningiomas: tumour cells in the arachnoid membrane. Surg Neurol 56:228–235PubMedCrossRef Kamitani H, Masuzawa H, Kanazawa I et al (2001) Recurrence of convexity meningiomas: tumour cells in the arachnoid membrane. Surg Neurol 56:228–235PubMedCrossRef
32.
go back to reference Kinjo T, al-Mefty O, Kanaan I (1993) Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 33:394–399PubMedCrossRef Kinjo T, al-Mefty O, Kanaan I (1993) Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 33:394–399PubMedCrossRef
Metadata
Title
Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density
Authors
Valeria Barresi
Enrica Vitarelli
Serenella Cerasoli
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 5/2009
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-009-0757-3

Other articles of this Issue 5/2009

Virchows Archiv 5/2009 Go to the issue